Accès gratuit
Numéro
Med Sci (Paris)
Volume 31, Numéro 1, Janvier 2015
Page(s) 53 - 59
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20153101013
Publié en ligne 6 février 2015
  1. Zumla A, Raviglione M, Hafner R, von Reyn CF. Tuberculosis. N Engl J Med 2013 ; 368 : 745–755. [CrossRef] [PubMed] [Google Scholar]
  2. Lai RP, Nakiwala JK, Meintjes G, Wilkinson RJ. The immunopathogenesis of the HIV tuberculosis immune reconstitution inflammatory syndrome. Eur J Immunol 2013 ; 43 : 1995–2002. [CrossRef] [PubMed] [Google Scholar]
  3. World-Health-Organization : Global tuberculosis report. 2013, URL: http://www.who.int/entity/tb/country/en/index.html. [Google Scholar]
  4. Aaron L, Saadoun D, Calatroni I, et al. Tuberculosis in HIV-infected patients: a comprehensive review. Clin Microbiol Infect 2004 ; 10 : 388–398. [CrossRef] [PubMed] [Google Scholar]
  5. Gandhi NR, Moll A, Sturm AW et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006 ; 368 : 1575–1580. [CrossRef] [PubMed] [Google Scholar]
  6. Meintjes G, Lawn SD, Scano F. et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis 2008 ; 8 : 516–523. [CrossRef] [PubMed] [Google Scholar]
  7. Breton G, Duval X, Estellat C. et al. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis 2004 ; 39 : 1709–1712. [CrossRef] [PubMed] [Google Scholar]
  8. Muller M, Wandel S, Colebunders R. et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 2010 ; 10 : 251–261. [CrossRef] [PubMed] [Google Scholar]
  9. French MA. HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis 2009 ; 48 : 101–107. [CrossRef] [PubMed] [Google Scholar]
  10. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS 2004 ; 18 : 1615–1627. [CrossRef] [PubMed] [Google Scholar]
  11. Haddow LJ, Colebunders R, Meintjes G. et al. Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis 2010 ; 10 : 791–802. [CrossRef] [PubMed] [Google Scholar]
  12. Breton G., Schaaf HS, Zumla A. Immune reconstitution inflammatory syndrome. Tuberculosis: a comprehensive clinical reference 2009 ; Philadelphia Saunders, Elsevier 689–700. [Google Scholar]
  13. Pepper DJ, Marais S, Maartens G. et al. Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. Clin Infect Dis 2009 ; 48 : e96–107. [CrossRef] [PubMed] [Google Scholar]
  14. French MA. The immunopathogenesis of mycobacterial immune restoration disease. Lancet Infect Dis 2006 ; 6 : 461–462. [CrossRef] [PubMed] [Google Scholar]
  15. Pean P, Nerrienet E, Madec Y. et al. Natural killer cell degranulation capacity predicts early onset of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients with tuberculosis. Blood 2012 ; 119 : 3315–3320. [CrossRef] [PubMed] [Google Scholar]
  16. Blanc FX, Sok T, Laureillard D. et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med 2011 ; 365 : 1471–1481. [CrossRef] [PubMed] [Google Scholar]
  17. Abdool Karim SS, Naidoo K, Grobler A. et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med 2011 ; 365 : 1492–1501. [CrossRef] [PubMed] [Google Scholar]
  18. Havlir DV, Kendall MA, Ive P. et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med 2011 ; 365 : 1482–1491. [CrossRef] [PubMed] [Google Scholar]
  19. Morlat P. Prise en charge médicale des personnes vivant avec le VIH : Recommandations du groupe d’experts. Rapport 2013. Conseil national du Sida et Agence nationale de recherche sur le Sida et les hépatites virales 2013. URL: http://www.sante.gouv.fr/IMG/pdf/Rapport_Morlat_2013_Mise_en_ligne.pdf. [Google Scholar]
  20. Bourgarit A, Carcelain G, Martinez V. et al. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS 2006 ; 20 : F1–F7. [CrossRef] [PubMed] [Google Scholar]
  21. Mahnke YD, Greenwald JH, DerSimonian R. et al. Selective expansion of polyfunctional pathogen-specific CD4+ T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome. Blood 2012 ; 119 : 3105–3112. [CrossRef] [PubMed] [Google Scholar]
  22. Geldmacher C, Schuetz A, Ngwenyama N. et al. Early depletion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection. J Infect Dis 2008 ; 198 : 1590–1598. [CrossRef] [PubMed] [Google Scholar]
  23. Geldmacher C, Ngwenyama N, Schuetz A. et al. Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J Exp Med 2010 ; 207 : 2869–2881. [CrossRef] [PubMed] [Google Scholar]
  24. Tan DB, Yong YK, Tan HY. et al. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis. HIV Med 2008 ; 9 : 307–316. [CrossRef] [PubMed] [Google Scholar]
  25. Elliott JH, Vohith K, Saramony S. et al. Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy. J Infect Dis 2009 ; 200 : 1736–1745. [CrossRef] [PubMed] [Google Scholar]
  26. Bourgarit A, Carcelain G, Samri A, et al. Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells. J Immunol 2009; 183 : 3915–3923. [CrossRef] [PubMed] [Google Scholar]
  27. Sereti I, Rodger AJ, French MA. Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesis. Curr Opin HIV AIDS 2010 ; 5 : 504–510. [CrossRef] [PubMed] [Google Scholar]
  28. Barber DL, Andrade BB, Sereti I, Sher A. Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none. Nat Rev Microbiol 2012 ; 10 : 150–156. [PubMed] [Google Scholar]
  29. Tadokera R, Meintjes G, Skolimowska KH. et al. Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome. Eur Respir J 2011 ; 37 : 1248–1259. [CrossRef] [PubMed] [Google Scholar]
  30. Lortholary O, Fontanet A, Memain N. et al. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 2005 ; 19 : 1043–1049. [CrossRef] [PubMed] [Google Scholar]
  31. Lawn SD, Wainwright H, Orrell C. Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages. AIDS 2009 ; 23 : 143–145. [CrossRef] [PubMed] [Google Scholar]
  32. Barber DL, Mayer-Barber KD, Antonelli LR. et al. Th1-driven immune reconstitution disease in Mycobacterium avium-infected mice. Blood 2010 ; 116 : 3485–3493. [CrossRef] [PubMed] [Google Scholar]
  33. Tan DB, Lim A, Yong YK. et al. TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease. AIDS 2011 ; 25 : 1455–1460. [CrossRef] [PubMed] [Google Scholar]
  34. Porter BO, Ouedraogo GL, Hodge JN. et al. d-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS. Clin Immunol 2010 ; 136 : 42–50. [CrossRef] [PubMed] [Google Scholar]
  35. Narendran G, Andrade BB, Porter BO. et al. Paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV patients with culture confirmed pulmonary tuberculosis in India and the potential role of IL-6 in prediction. PLoS One 2013 ; 8 : e63541. [CrossRef] [PubMed] [Google Scholar]
  36. Goovaerts O, Jennes W, Massinga-Loembe M. et al. LPS-binding protein and IL-6 mark paradoxical tuberculosis immune reconstitution inflammatory syndrome in HIV patients. PLoS One 2013 ; 8 : e81856. [CrossRef] [PubMed] [Google Scholar]
  37. Oliver BG, Elliott JH, Price P. et al. Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy. J Infect Dis 2010 ; 202 : 1728–1737. [CrossRef] [PubMed] [Google Scholar]
  38. Chakrabarti LA, Boucherie C, Bugault F. et al. Biomarkers of CD4+ T cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 2014 ; 28 : 1593–1602. [CrossRef] [PubMed] [Google Scholar]
  39. Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 2011 ; 62 : 141–155. [CrossRef] [PubMed] [Google Scholar]
  40. Napolitano LA, Grant RM, Deeks SG. et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 2001 ; 7 : 73–79. [CrossRef] [PubMed] [Google Scholar]
  41. Chahroudi A, Silvestri G. Interleukin-7 in HIV pathogenesis and therapy. Eur Cytokine Netw 2010 ; 21 : 202–207. [PubMed] [Google Scholar]
  42. Juffroy O, Bugault F, Lambotte O. et al. Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway. J Virol 2010 ; 84 : 96–108. [CrossRef] [PubMed] [Google Scholar]
  43. Landires I, Bugault F, Lambotte O. et al. HIV infection perturbs interleukin-7 signaling at the step of STAT5 nuclear relocalization. AIDS 2011 ; 25 : 1843–1853. [CrossRef] [PubMed] [Google Scholar]
  44. Seddiki N, Sasson SC, Santner-Nanan B, et al. Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease. Eur J Immunol 2009; 39 : 391–403. [CrossRef] [PubMed] [Google Scholar]
  45. Antonelli LR, Mahnke Y, Hodge JN. et al. Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome. Blood 2010 ; 116 : 3818–3827. [CrossRef] [PubMed] [Google Scholar]
  46. Borand L, Pheng P, Saman M. et al. Co-infection tuberculose et VIH. Med Sci (Paris) 2013 ; 29 : 908–911. [CrossRef] [EDP Sciences] [Google Scholar]
  47. Veziris N, Robert J. Résistance aux antituberculeux et impasse thérapeutique. Med Sci (Paris) 2010 ; 26 : 976–980. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  48. Breton G.. Syndrome inflammatoire de reconstitution immune. Med Sci (Paris) 2010 ; 26 : 281–290. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  49. Gouzy A. Yannick Poquet Y, Neyrolles O. L’aspartate : un acide aminé essentiel à la physiologie et à la virulence du bacille de la tuberculose. Med Sci (Paris) 2014 ; 30 : 242–244. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.